# Nuveen Real Asset Income and Growth Fund of Beneficial Interest (JRI) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Financial Services / Capital Markets. Price $11.36, market value $411 million.

## Valuation
- **P/E (trailing): 7.8×** (5-yr avg 8.4×, 3-yr avg 8.4×). Nuveen Real Asset Income and Growth Fund of Beneficial Interest trades at 7.8× trailing earnings, close to its own five-year average of 8.4×. The Financial Services median in the September 2026 study was 13.1×.
- **Price / sales: 8.2×**. Each dollar of revenue is priced at 8.2×.
- **Price / book: 1.1×**. The shares trade at 1.1× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: 12.8%** (5-yr avg 16.1%). Free cash flow equals 12.8% of the market value, below its five-year average of 16.1%, so the shares are pricier on cash than usual. Above 5% is generally attractive.
- **Earnings yield: 12.9%**. The inverse of the P/E: 12.9% of the price is earned each year.

## Profitability
- **Net margin: 97.5%**. 97.5% of each dollar of sales reaches the bottom line.
- **Return on equity: 13.4%**. 13.4% on shareholders' equity is solid.
- **Return on assets: 9.0%**. Each dollar of assets produces 9.0% of profit; low single digits are normal for banks and insurers.

## Growth
- **Revenue growth (1 yr): 82.8%**. Revenue grew 82.8% over the last year.
- **EPS growth (1 yr): 91.4%**. Earnings per share rose 91.4%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -1.2%/yr**. Free cash flow has compounded at -1.2% a year over three years.

## Financial health
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.
- **Cash and short-term investments: $889,782**. Leverage ratios are shown differently for banks and insurers, whose balance sheets are built on deposits and reserves; use return on equity and the regulatory capital in the filings instead.

## Dividends
- **Dividend yield: 14.10%** ($1.60 per share, trailing). Nuveen Real Asset Income and Growth Fund of Beneficial Interest yields 14.10%, high enough to check carefully: yields this high often precede a cut.
- **Payout ratio: 89%** (83% of free cash flow). 89% of earnings goes out as dividends, leaving a thin cushion.
- **Consecutive years of increases: 2**. 2 straight years of increases.
- **Dividend growth (5 yr): 5.6%/yr** (1-yr 11.8%). The dividend has grown 5.6% a year over five years.

## Price and momentum
- **Total return (1 yr): -10.6%** (YTD -10.5%, 3-mo -12.2%). The shares are down 10.6% over twelve months including dividends.
- **From 52-week high: -17.8%** (10.2% above the low). Trading 18% below its 52-week high.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 63**. An RSI of 63 is neutral.
- **Beta (1 yr): 0.47** (volatility 16%). Beta of 0.47 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=JRI · Page: https://foliofundamentals.com/stocks/jri

Not investment advice.